Search results
Earnings call: Xenon Pharmaceuticals reports on Q1 2024 progress
Investing.com· 16 hours agoThe company discussed the advancement of its Phase 3 epilepsy program and the initiation of Phase 3...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 18 hours agoBut many insurance companies have on their drug formulary only the generic form. So all patients can...
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 3 days agoThe company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 1 day agoSales of generics-facing Alimta, a cancer drug, are also forecast to drop. Eli Lilly Stock ...Shares...
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 day agoAdditionally...a Price/Cash Flow ratio of 14.1X. Value investors should also note RDY's Price/Sales...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoHowever, that business understandably dried up as the pandemic passed, and the giant hole left in...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 1 day agoHere's why it's a great stock for income-seeking investors to buy now and hold for the long run. Not...
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 15 hours agoChanges in healthcare policies, pricing pressures, and the introduction of generics and biosimilars can significantly impact the sales of products...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 2 days agoThe company expects Austedo to generate $2.5 billion in revenue by 2027...Rated Pharma Stock...
Teva Pharm Q1 profit misses estimates, revenue rises By Reuters
Investing.com· 2 days agoThe world's largest generic drugmaker said on Wednesday it earned 48 cents per diluted share excluding one-time items in the January-March...higher impairments of tangible ...